UK Health Security Agency Issues Class 2 Recall for Advanz Pharma's Mynzepli Solution for Injection

Advanz Pharma Limited is recalling specific batches of Mynzepli 40 mg/mL solution for injection in pre-filled syringes as a precautionary measure. The Class 2 recall, issued by the UK Health Security Agency (UKHSA), is due to a small variation in the size of the finger grip, which could affect how the medicine is administered and potentially pose a risk to patient safety.